A vaginal swab, a molecular signal and a $45 million wager: PinkDx wants to help doctors rule out endometrial cancer before women endure an invasive workup.
Single-target cancer drugs can teach tumors how to route around them. Faeth’s answer is PIKTOR - two oral medicines, three pathway nodes and a public-company-sized test of whether deeper blockade can stay tolerable.